Moxifloxacin–Tetracycline–Lansoprazole Triple Therapy for First-Line Treatment of Helicobacter pylori Infection: A Prospective Study
Helicobacter, 01/24/2011
Clinical Article
Tas A et al. – The moxifloxacine–tetracycline–lansoprazole regimen failed to achieve the recommended eradication rates and had higher adverse effect rate. Hence, moxifloxacine–tetracycline–lansoprazole regimen does not seem to be a suitable choice as a first–line Helicobacter pylori eradication therapy.



